Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment?
Mattia C. F. ProsperiSarah L. InghamAnthony HowellFiona LallooIain E. BuchanDafydd Gareth EvansPublished in: BMC Medical Informatics Decis. Mak. (2014)